-
-
Type II diabetes.
-
-
Fibromyalgia.
-
-
Anemia.
-
-
Coagulation disorders or taking anticoagulants.
-
-
Pregnancy or lactation.
-
-
Allergic to a steroid drug or hyaluronic acid.
-
-
Large (more than 10 mL of aspirated synovial fluid) effusion in the knee joint or abnormal synovial fluid appearance.
-
-
A history of purulent inflammation of the knee.
-
-
Rheumatic diseases and systemic diseases of connective tissue.
-
-
Active neoplastic disease.
-
-
The patient is undergoing oral steroid therapy, antibiotic therapy or biological treatment.
-
-
The patient received an intra-articular injection into the examined joint in less than a year before the screening visit.
-
-
The patient had previous operations, fractures, ligaments or meniscus injuries in the area of the examined lower limb.
-
-
The patient has a Baker’s cyst.
-
-
The patient is addicted to nicotine, alcohol, or drugs.
-
-
The patient had an injury to the examined knee joint within one month of the screening visit.
-
-
The patient has a significant deformation of the examined knee joint.
-
-
There is a valgus or varus greater than 10° in any of the knees.
-
-
The range of motion of the knee joint is less than 100°.
-
-
Major axial deviation (varus > 5, valgus > 5).
-
-
Any concomitant symptomatic knee disorder (i.e., ligamentous or meniscal injury).
-
-
Hematologic disease.
-
-
Active infection.
-
-
Recent intra-articular injection of corticosteroid or HA in past 6 months.